Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, November 26, 2020 · 531,517,565 Articles · 3+ Million Readers

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Cleveland BioLabs, Inc. Merger

/EIN News/ -- WILMINGTON, Del., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Cleveland BioLabs, Inc. (“Cleveland”) (NASDAQ GS: CBLI) regarding possible breaches of fiduciary duties and other violations of law related to Cleveland’s agreement to merge with Cytocom, Inc. (“Cytocom”). Under the terms of the agreement, Cleveland will issue a number of shares of Cleveland common stock to shareholders of Cytocom.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-cleveland-biolabs-inc.

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com.

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT:

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com
https://rl-legal.com

Primary Logo

Powered by EIN News
Distribution channels: Consumer Goods, Law


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release